France's OTC Market in 2018: Self-Medication Sales Slump, Sanofi Claims Number-One Spot

France's self-medication market had a difficult 2018, due to a weak flu season and changing dynamics in the sector, according to industry association Afipa. Despite this it was a good year for Sanofi, which overtook Boiron as the number-one OTC firm in the market, while its Doliprane analgesic became France's best-selling brand.

France
• Source: Shutterstock

Self-medication sales in France declined by 4.6% to €2.11bn in 2018, reported local industry association Afipa, which blamed the single-digit decline on a poor flu season and changing market dynamics.

Incidence of cold and flu at the start of 2018 had been lower than in 2017, Afipa noted, and this had been compounded by the 2018/2019 season beginning much later in the year than expected

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography